Follow
Mark Simons
Mark Simons
Verified email at usuhs.edu
Title
Cited by
Cited by
Year
Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates
CA Duplessis, M Bavaro, MP Simons, C Marguet, M Santomauro, B Auge, ...
Urology 79 (3), 556-563, 2012
1742012
Resistencia emergente a los antibióticos: una amenaza global y un problema crítico en el cuidado de la salud
C Rocha, ND Reynolds, MP Simons
Revista Peruana de Medicina Experimental y Salud Pública 32, 139-145, 2015
1612015
Role of neutrophils in BCG immunotherapy for bladder cancer
MP Simons, MA O'Donnell, TS Griffith
Urologic Oncology: Seminars and Original Investigations 26 (4), 341-345, 2008
1532008
SARS-CoV-2 transmission among Marine recruits during quarantine
AG Letizia, I Ramos, A Obla, C Goforth, DL Weir, Y Ge, MM Bamman, ...
New England Journal of Medicine 383 (25), 2407-2416, 2020
1272020
Interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes
MP Simons, WM Nauseef, MA Apicella
Infection and immunity 73 (4), 1971-1977, 2005
1192005
SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ...
Science translational medicine 14 (645), eabn8543, 2022
782022
Neisseria gonorrhoeae delays the onset of apoptosis in polymorphonuclear leukocytes
MP Simons, WM Nauseef, TS Griffith, MA Apicella
Cellular microbiology 8 (11), 1780-1790, 2006
722006
Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer
MP Simons, WM Nauseef, TS Griffith
Immunologic research 39, 79-93, 2007
652007
Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) study: a randomized controlled trial comparing 3 single-dose antibiotic regimens with loperamide
MS Riddle, P Connor, J Fraser, CK Porter, B Swierczewski, EJ Hutley, ...
Clinical Infectious Diseases 65 (12), 2008-2017, 2017
612017
Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils
MP Simons, JM Moore, TJ Kemp, TS Griffith
Infection and immunity 75 (3), 1265-1271, 2007
612007
Investigation of oxidative stress defenses of Neisseria gonorrhoeae by using a human polymorphonuclear leukocyte survival assay
KL Seib, MP Simons, HJ Wu, AG McEwan, WM Nauseef, MA Apicella, ...
Infection and immunity 73 (8), 5269-5272, 2005
432005
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
S Lusvarghi, SD Pollett, SN Neerukonda, WEI WANG, R Wang, R Vassell, ...
bioRxiv, 2021
412021
The genetic diversity of influenza A viruses in wild birds in Peru
MI Nelson, S Pollett, B Ghersi, M Silva, MP Simons, E Icochea, ...
PloS one 11 (1), e0146059, 2016
402016
TNF‐related apoptosis‐inducing ligand (TRAIL) is expressed throughout myeloid development, resulting in a broad distribution among neutrophil granules
MP Simons, KG Leidal, WM Nauseef, TS Griffith
Journal of leukocyte biology 83 (3), 621-629, 2008
392008
Burden of influenza in 4 ecologically distinct regions of Peru: household active surveillance of a community cohort, 2009–2015
YO Tinoco, E Azziz-Baumgartner, TM Uyeki, HR Rázuri, MR Kasper, ...
Clinical Infectious Diseases 65 (9), 1532-1541, 2017
382017
Durability of SARS-CoV-2–Specific T-Cell Responses at 12 Months Postinfection
Z Lu, ED Laing, J Pena DaMata, K Pohida, MS Tso, EC Samuels, NJ Epsi, ...
The Journal of infectious diseases 224 (12), 2010-2019, 2021
372021
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
SA Richard, SD Pollett, AC Fries, CM Berjohn, RC Maves, T Lalani, ...
JAMA Network Open 6 (1), e2251360-e2251360, 2023
362023
Impact of Frequent Administration of Bacteriophage on Therapeutic Efficacy in an A. baumannii Mouse Wound Infection Model
MD Rouse, J Stanbro, JA Roman, MA Lipinski, A Jacobs, B Biswas, ...
Frontiers in microbiology 11, 414, 2020
352020
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
W Wang, S Lusvarghi, R Subramanian, NJ Epsi, R Wang, E Goguet, ...
Cell host & microbe 30 (12), 1745-1758. e7, 2022
322022
The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity
SD Pollett, SA Richard, AC Fries, MP Simons, K Mende, T Lalani, T Lee, ...
Clinical Infectious Diseases, 2021
322021
The system can't perform the operation now. Try again later.
Articles 1–20